Cargando…
Bilateral Central Serous Chorioretinopathy After Treatment of COVID-19 Infection
We report a rare case of bilateral central serous chorioretinopathy (CSCR) after COVID-19 management with steroids. The patient was a 49-year-old female who presented with bilateral blurred vision three months after the COVID-19 infection. She had been treated with intravenous Remdesivir and Dexamet...
Autores principales: | Sharifi, Ali, Daneshtalab, Arash, Zand, Amin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038508/ https://www.ncbi.nlm.nih.gov/pubmed/35494916 http://dx.doi.org/10.7759/cureus.23446 |
Ejemplares similares
-
Bilateral and Multiple Central Serous Chorioretinopathy Following COVID-19 Infection: A Case Report and Literature Review
por: Mohd-Alif, W Mohd, et al.
Publicado: (2022) -
Interobserver Agreement of Novel Classification of Central Serous Chorioretinopathy
por: Sahoo, Niroj K, et al.
Publicado: (2022) -
Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016) -
Aflibercept as a Treatment for Secondary Central Serous Chorioretinopathy in a Patient With Myasthenia Gravis
por: Ramirez Marquez, Estefania, et al.
Publicado: (2022) -
Retinal Imaging and Optical Coherence Tomography of Choroidal Haemangioma Mimicking Central Serous Chorioretinopathy
por: Jugnarain, Davina, et al.
Publicado: (2023)